The price of Aura Biosciences Inc (NASDAQ: AURA) closed at $7.85 in the last session, up 1.95% from day before closing price of $7.70. In other words, the price has increased by $+0.15 from its previous closing price. On the day, 323825 shares were traded.
Ratios:
We take a closer look at AURA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 18.76 and its Current Ratio is at 18.76. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.07.
On July 19, 2022, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $26.JMP Securities initiated its Mkt Outperform rating on July 19, 2022, with a $26 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 23 ’24 when de los Pinos Elisabet sold 15,853 shares for $7.64 per share. The transaction valued at 121,141 led to the insider holds 161,438 shares of the business.
Feder Julie B sold 6,609 shares of AURA for $50,521 on Jan 23 ’24. The Chief Financial Officer now owns 62,991 shares after completing the transaction at $7.64 per share. On Nov 09 ’23, another insider, Matrix Capital Management Comp, who serves as the 10% Owner of the company, bought 1,560,000 shares for $9.00 each. As a result, the insider paid 14,040,000 and bolstered with 6,922,870 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AURA now has a Market Capitalization of 379.30M and an Enterprise Value of 250.43M.
Stock Price History:
Over the past 52 weeks, AURA has reached a high of $13.50, while it has fallen to a 52-week low of $5.99. The 50-Day Moving Average of the stock is 8.21, while the 200-Day Moving Average is calculated to be 9.42.
Shares Statistics:
According to the various share statistics, AURA traded on average about 181.21K shares per day over the past 3-months and 461.95k shares per day over the past 10 days. A total of 49.35M shares are outstanding, with a floating share count of 39.68M. Insiders hold about 19.34% of the company’s shares, while institutions hold 72.14% stake in the company. Shares short for AURA as of Mar 15, 2024 were 2.24M with a Short Ratio of 12.36, compared to 2.53M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 4.54% and a Short% of Float of 5.38%.
Earnings Estimates
The company has 3 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.5 for the current quarter, with a high estimate of -$0.44 and a low estimate of -$0.57, while EPS last year was -$0.46. The consensus estimate for the next quarter is -$0.51, with high estimates of -$0.45 and low estimates of -$0.57.
Analysts are recommending an EPS of between -$1.67 and -$2.24 for the fiscal current year, implying an average EPS of -$1.91. EPS for the following year is -$2.07, with 3 analysts recommending between -$1.64 and -$2.38.
